Genspace Event: A New Strategy Against Blood Cancers
Dr. Julian Adams on "A New Strategy Against Blood Cancers"
Friday, December 13, 2013 from 7:00 PM - 8:00 PM
Join us at Genspace for a presentation by Dr. Julian Adams, the President of research and development at Infinty Pharmaceuticals. Dr. Adams’s work has led to the development of a new class of anti-cancer drugs, proteosome inhibitors, that target multiple myelomas. Find out how rapid progress being made in the field of anti-cancer drug development is hoped to lead to the eventual eradication of all forms of cancer.
Dr. Adams has been recently honored by The Mass General Cancer Center for his efforts and success in leading the way towards curing cancer: http://www.theonehundred.org/honorees/view/julian-adams-phd/